Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab

Bibliographic Details
Main Authors: Changhua Zhu, MD, Jie Shen Fok, MD, Lihang Lin, MD, Huichun Su, MD, Marcus Maurer, MD
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:JAAD Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512622005501
_version_ 1797904324649549824
author Changhua Zhu, MD
Jie Shen Fok, MD
Lihang Lin, MD
Huichun Su, MD
Marcus Maurer, MD
author_facet Changhua Zhu, MD
Jie Shen Fok, MD
Lihang Lin, MD
Huichun Su, MD
Marcus Maurer, MD
author_sort Changhua Zhu, MD
collection DOAJ
first_indexed 2024-04-10T09:48:17Z
format Article
id doaj.art-f540d11852854cfcafc98be4b648d249
institution Directory Open Access Journal
issn 2352-5126
language English
last_indexed 2024-04-10T09:48:17Z
publishDate 2023-02-01
publisher Elsevier
record_format Article
series JAAD Case Reports
spelling doaj.art-f540d11852854cfcafc98be4b648d2492023-02-17T04:54:57ZengElsevierJAAD Case Reports2352-51262023-02-0132109112Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumabChanghua Zhu, MD0Jie Shen Fok, MD1Lihang Lin, MD2Huichun Su, MD3Marcus Maurer, MD4Department of Dermatology, Fujian Medical University Union Hospital, Fuzhou, ChinaDepartment of Respiratory Medicine and General Medicine, Box Hill Hospital, Eastern Health, Victoria, Australia; Allergy/Immunology, Monash Medical Centre, Monash Health, Victoria, AustraliaDepartment of Dermatology, Fujian Medical University Union Hospital, Fuzhou, China; Correspondence to: Lihang Lin, MDDepartment of Dermatology, Fujian Medical University Union Hospital, Fuzhou, China; Huichun Su, MD, Department of Dermatology, Fujian Medical University Union Hospital, Xianquan Road 29, Fuzhou, Fujian 350001, China.Institute of Allergology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germanyhttp://www.sciencedirect.com/science/article/pii/S2352512622005501chronic spontaneous urticariadupilumabeosinopholia
spellingShingle Changhua Zhu, MD
Jie Shen Fok, MD
Lihang Lin, MD
Huichun Su, MD
Marcus Maurer, MD
Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
JAAD Case Reports
chronic spontaneous urticaria
dupilumab
eosinopholia
title Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
title_full Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
title_fullStr Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
title_full_unstemmed Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
title_short Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
title_sort complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
topic chronic spontaneous urticaria
dupilumab
eosinopholia
url http://www.sciencedirect.com/science/article/pii/S2352512622005501
work_keys_str_mv AT changhuazhumd completeresponsetodupilumabinapatientwithchronicspontaneousurticariawhodidnottolerateomalizumab
AT jieshenfokmd completeresponsetodupilumabinapatientwithchronicspontaneousurticariawhodidnottolerateomalizumab
AT lihanglinmd completeresponsetodupilumabinapatientwithchronicspontaneousurticariawhodidnottolerateomalizumab
AT huichunsumd completeresponsetodupilumabinapatientwithchronicspontaneousurticariawhodidnottolerateomalizumab
AT marcusmaurermd completeresponsetodupilumabinapatientwithchronicspontaneousurticariawhodidnottolerateomalizumab